These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3198495)

  • 21. The activity of 4''-acylated tylosin derivatives against macrolide-resistant gram-positive bacteria.
    Okamoto R; Nomura H; Tsuchiya M; Tsunekawa H; Fukumoto T; Inui T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1979 May; 32(5):542-4. PubMed ID: 528400
    [No Abstract]   [Full Text] [Related]  

  • 22. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
    Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
    J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 4'-deoxymycaminosyl tylonolide.
    Tanaka A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1374-6. PubMed ID: 7309633
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
    Sano H; Inoue M; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activity.
    Sakamoto S; Tsuchiya T; Tanaka A; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1985 Apr; 38(4):477-84. PubMed ID: 4008340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spiramycin derivatives. 1].
    Takahira H
    Jpn J Antibiot; 1970 Aug; 23(4):424-8. PubMed ID: 5312794
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 9-epi-leucomycin A5. Synthesis and antimicrobial activity.
    Sakakibara H; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Dec; 34(12):1577-80. PubMed ID: 7333970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses of 4'-deoxy-demycarosyl tylosin and its analogues.
    Tanaka A; Watanabe A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1381-4. PubMed ID: 7309635
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function: a new series of orally effective antibiotics.
    Kirst HA; Toth JE; Debono M; Willard KE; Truedell BA; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
    J Med Chem; 1988 Aug; 31(8):1631-41. PubMed ID: 3398001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
    Omura S; Matsubara H; Tsuzuki K; Nakagawa A
    J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits.
    Siegrist S; Lagouardat J; Moreau N; LeGoffic F
    Eur J Biochem; 1981 Apr; 115(2):323-7. PubMed ID: 6786880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.